GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · IEX Real-Time Price · USD
2.765
+0.045 (1.65%)
At close: Jul 26, 2024, 3:27 PM
2.710
-0.055 (-1.99%)
After-hours: Jul 26, 2024, 6:51 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $5.96 million as of July 26, 2024. Its market cap has decreased by -43.21% in one year.
Market Cap
5.96M
Enterprise Value
-3.81M
1-Year Change
-43.21%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $5.96M, a decrease of -92.83%. That is a compound annual growth rate of -34.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 3.90M | -63.21% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 6.50M |
| Virios Therapeutics | 6.43M |
| ReShape Lifesciences | 6.21M |
| Alaunos Therapeutics | 6.04M |
| FSD Pharma | 6.00M |
| Innovative Eyewear | 5.91M |
| Biomerica | 5.88M |
| PolyPid | 5.79M |